Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like World’s Largest Factory for Green Refrigerants Opens in Texas February 26, 2019 Inside Indian industry’s big defence play September 26, 2017 Hexagon’s Manufacturing Intelligence division announces PC-DMIS 2019 R1 March 1, 2019